A share price of Novartis AG ADR [NVS] is currently trading at $98.35, up 1.10%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The NVS shares have gain 5.66% over the last week, with a monthly amount glided 2.74%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Novartis AG ADR [NYSE: NVS] stock has seen the most recent analyst activity on February 23, 2024, when BMO Capital Markets initiated its Market Perform rating and assigned the stock a price target of $114. Previously, Morgan Stanley started tracking the stock with Equal-Weight rating on January 23, 2024, and set its price target to $114. HSBC Securities downgraded its rating to a Hold. Morgan Stanley upgraded its rating to a Equal-Weight. In a note dated April 26, 2023, Deutsche Bank upgraded an Buy rating on this stock.
Novartis AG ADR experienced fluctuations in its stock price throughout the past year between $88.86 and $108.78. Currently, Wall Street analysts expect the stock to reach $108 within the next 12 months. Novartis AG ADR [NYSE: NVS] shares were valued at $98.35 at the most recent close of the market. An investor can expect a potential return of 9.81% based on the average NVS price forecast.
Analyzing the NVS fundamentals
Trailing Twelve Months sales for Novartis AG ADR [NYSE:NVS] were 49.78B which represents -9.98% decline. Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at 0.2%, Pretax Profit Margin comes in at 0.19%, and Net Profit Margin reading is 0.29%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.31 and Total Capital is 0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.56.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 97.65 points at the first support level, and at 96.96 for the second support level. However, for the 1st resistance point, the stock is sitting at 98.80, and for the 2nd resistance point, it is at 99.25.
Novartis AG ADR [NVS] reported earnings per share of $1.8 for its fiscal quarter that ended on 3/31/2024. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $1.69/share, meaning a difference of $0.11 and a surprise factor of 6.50%. By comparison, the stated earnings for the previous quarter ended on 12/31/2023 were $1.53 per share as compared to estimates of $1.68 per share, a difference of -$0.15 representing a surprise of -8.90%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Novartis AG ADR [NYSE:NVS] is 1.16. As well, the Quick Ratio is 0.93, while the Cash Ratio is 0.51. Considering the valuation of this stock, the price to sales ratio is 3.87, the price to book ratio is 4.31 and price to earnings (TTM) ratio is 13.77.
